Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anne-Florence Christelle Blandin, Ph.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Anne-Florence Blandin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Anne-Florence Blandin has written about over time.
Brain Neoplasms, 1 publications between 2020 and 2020, average publication date November 2020. Cell Line, Tumor, 1 publications between 2020 and 2020, average publication date November 2020. Cell Membrane, 1 publications between 2020 and 2020, average publication date November 2020. Cell Movement, 1 publications between 2020 and 2020, average publication date November 2020. Endocytosis, 1 publications between 2020 and 2020, average publication date November 2020. Endosomes, 1 publications between 2020 and 2020, average publication date November 2020. Epidermal Growth Factor, 1 publications between 2020 and 2020, average publication date November 2020. Glioblastoma, 1 publications between 2020 and 2020, average publication date November 2020. Humans, 1 publications between 2020 and 2020, average publication date November 2020. Integrin alpha5beta1, 1 publications between 2020 and 2020, average publication date November 2020. Protein Kinase Inhibitors, 1 publications between 2020 and 2020, average publication date November 2020. RNA Interference, 1 publications between 2020 and 2020, average publication date November 2020. RNA, Small Interfering, 1 publications between 2020 and 2020, average publication date November 2020.

To see the data from this visualization as text, click here.
Blandin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.